The Effect of IL-7 (CYT107) on CD4 Counts in Patients With High Grade Gliomas and Severe Treatment-Related CD4 Lymphopenia After Concurrent Radiation and Temozolomide
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Interleukin-7 (Primary)
- Indications Lymphopenia
- Focus Therapeutic Use
- 25 May 2017 Planned End Date changed from 1 Aug 2018 to 1 Aug 2020.
- 25 May 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2019.
- 25 May 2017 Status changed from recruiting to suspended.